Clinical Trials Logo

Stage IVA Prostate Cancer clinical trials

View clinical trials related to Stage IVA Prostate Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03827473 Terminated - Clinical trials for Stage IV Prostate Cancer

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

ACADEMIC
Start date: February 8, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well docetaxel or abiraterone acetate work when combined with androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread to other parts of the body. Drugs used in chemotherapy, such as docetaxel and abiraterone acetate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Antihormone therapy, such as ADT may lessen the amount of androgen made by the body. It is not yet known whether docetaxel or abiraterone acetate work better when combined with ADT in treating patients with hormone sensitive prostate cancer.